181 related articles for article (PubMed ID: 18596869)
1. Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f ] quinoline in mice.
Yuan JH; Li YQ; Yang XY
Mol Med; 2008; 14(9-10):590-8. PubMed ID: 18596869
[TBL] [Abstract][Full Text] [Related]
2. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice.
Zhang ZM; Yang XY; Yuan JH; Sun ZY; Li YQ
Chin Med J (Engl); 2009 Jul; 122(14):1660-5. PubMed ID: 19719968
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the Nrf2-UGT1A signal pathway in nude mice.
Yuan JH; Li YQ; Yang XY
Pharmacology; 2007; 80(4):269-78. PubMed ID: 17657175
[TBL] [Abstract][Full Text] [Related]
4. [The role of NF-E2-related factor 2 in the induction of uridine 5'-diphosphate-glucuronosyltransferase 1A and its isoforms by epigallocatechin gallate in colon cancer cells].
Yang XY; Zhao WP; Li YQ; Sun ZY; Zhang Y; Guo YT; Yuan JH; Zhu Q; Wang M
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):82-7. PubMed ID: 16620709
[TBL] [Abstract][Full Text] [Related]
5. Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat.
Xu M; Bailey AC; Hernaez JF; Taoka CR; Schut HA; Dashwood RH
Carcinogenesis; 1996 Jul; 17(7):1429-34. PubMed ID: 8706244
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.
Ohishi T; Kishimoto Y; Miura N; Shiota G; Kohri T; Hara Y; Hasegawa J; Isemura M
Cancer Lett; 2002 Mar; 177(1):49-56. PubMed ID: 11809530
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention studies of heterocyclic amine-induced colon carcinogenesis.
Xu M; Dashwood RH
Cancer Lett; 1999 Sep; 143(2):179-83. PubMed ID: 10503900
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen.
Kassie F; Uhl M; Rabot S; Grasl-Kraupp B; Verkerk R; Kundi M; Chabicovsky M; Schulte-Hermann R; Knasmüller S
Carcinogenesis; 2003 Feb; 24(2):255-61. PubMed ID: 12584175
[TBL] [Abstract][Full Text] [Related]
9. The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine (PhIP) in the development of colon cancer in mice.
Kristiansen E
Cancer Lett; 1996 Dec; 110(1-2):187-92. PubMed ID: 9018100
[TBL] [Abstract][Full Text] [Related]
10. Chemoprotective effects of garden cress (Lepidium sativum) and its constituents towards 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ)-induced genotoxic effects and colonic preneoplastic lesions.
Kassie F; Rabot S; Uhl M; Huber W; Qin HM; Helma C; Schulte-Hermann R; Knasmüller S
Carcinogenesis; 2002 Jul; 23(7):1155-61. PubMed ID: 12117773
[TBL] [Abstract][Full Text] [Related]
11. Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts.
Carter O; Dashwood RH; Wang R; Dashwood WM; Orner GA; Fischer KA; Löhr CV; Pereira CB; Bailey GS; Williams DE
Nutr Cancer; 2007; 58(1):60-5. PubMed ID: 17571968
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
[TBL] [Abstract][Full Text] [Related]
13. Effect of carcinogen dose fractionation, diet and source of F344 rat on the induction of colonic aberrant crypts by 2-amino-3-methylimidazo[4,5-f]quinoline.
Xu M; Chen R; Dashwood RH
Carcinogenesis; 1999 Dec; 20(12):2293-8. PubMed ID: 10590222
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive effect of sulindac in combination with epigallocatechin gallate or kaempferol against 1,2-dimethyl hydrazine-induced preneoplastic lesions in rats: A Comparative Study.
Hassanein NMA; Hassan ESG; Hegab AM; Elahl HMS
J Biochem Mol Toxicol; 2018 Oct; 32(10):e22198. PubMed ID: 29999212
[TBL] [Abstract][Full Text] [Related]
15. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
[TBL] [Abstract][Full Text] [Related]
16. Protection of conjugated linoleic acids against 2-amino-3- methylimidazo[4,5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms.
Liew C; Schut HA; Chin SF; Pariza MW; Dashwood RH
Carcinogenesis; 1995 Dec; 16(12):3037-43. PubMed ID: 8603482
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent induction of aberrant crypt foci in the colons but no neoplastic lesions in the livers of heterozygous p53-deficient mice treated with low dose 2-amino-3-methylimidazo [4,5-f]quinoline.
Morimura K; Salim EI; Yamamoto S; Wanibuchi H; Fukushima S
Cancer Lett; 1999 Apr; 138(1-2):81-5. PubMed ID: 10378777
[TBL] [Abstract][Full Text] [Related]
18. Refined carbohydrate enhancement of aberrant crypt foci (ACF) in rat colon induced by the food-borne carcinogen 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ).
Kristiansen E; Meyer O; Thorup I
Cancer Lett; 1996 Aug; 105(2):147-51. PubMed ID: 8697437
[TBL] [Abstract][Full Text] [Related]
19. IQ (2-amino-3-methylimidazo[4,5-f]quinoline)-induced aberrant crypt foci and colorectal tumour development in rats fed two different carbohydrate diets.
Mølck AM; Meyer O; Kristiansen E; Thorup I
Eur J Cancer Prev; 2001 Dec; 10(6):501-6. PubMed ID: 11916348
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats.
Wang Y; Jin HY; Fang MZ; Wang XF; Chen H; Huang SL; Kong DS; Li M; Zhang X; Sun Y; Wang SM
World J Gastroenterol; 2020 May; 26(17):2064-2081. PubMed ID: 32536775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
